Commercialization Of Biospecimens

Commercialization of Biospecimens is the process by which human biological samples and their associated data are utilized for profit-driven research, development, or product creation within the biobanking context, distinguished from non-commercial uses by the pursuit of financial gain and proprietary control.

52

Publications

2.2K

Citations

217

Authors

139

Institutions

Publications per year

2017–2026

19

Authors

217

  1. PH
    Peter H. Watson

    University of Manitoba, Canada

    4 publications · 192 citations

    4

    h-index

  2. DN
    Dianne Nicol

    University of Tasmania, Australia

    3 publications · 165 citations

    3

    h-index

  3. CC
    Christine Critchley

    Swinburne University of Technology, Australia

    2 publications · 149 citations

    2

    h-index

  4. RB
    Rebecca Barnes

    BC Cancer Agency, Canada

    2 publications · 127 citations

    2

    h-index

  5. SB
    Sindy Babinszky

    BC Cancer Agency, Canada

    2 publications · 65 citations

    2

    h-index

1–5 of 217

Venues

  1. Biopreservation and Biobanking

    10 publications · 268 citations

    10

    h-index

  2. Journal of Community Genetics

    2 publications · 139 citations

    2

    h-index

  3. Applied Sciences

    1 publications · 53 citations

    1

    h-index

  4. Canadian Journal of Plant Pathology

    1 publications · 34 citations

    1

    h-index

  5. Molecular Medicine Today

    1 publications · 14 citations

    1

    h-index

1–5